Update to the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) PrEP guidelines – September 2020

Brand name:
- Tenofovir/Emtricitabine 300/200 APOTEX®
- Tenofovir Disoproxil Emtricitabine Mylan 300/200®
- Tenofovir EMT GH®
Pharmaceutical Company:
- Apotex Pty Ltd
- Alphapharm Pty Ltd (trading as Mylan)
- Generic Health Pty Ltd
Condition/Indication:
Meeting Date: September 2020
Public Summary Document (PSD) September 2020 PBAC Meeting - (PDF 1203KB)
Public Summary Document (PSD) September 2020 PBAC Meeting - (Word 76KB)

Last updated

8 July 2025